Evidence map›Paper›PMID 26728565›Full record

ArticleMolecular psychiatry2016

The autism-associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain.

Y Peng, Z Lu, G Li, M Piechowicz, M Anderson, Y Uddin, J Wu, S Qiu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. HGF and MET: From Brain Development to Neurological Disorders.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Y PengDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
Z LuDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
G LiDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
M PiechowiczDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
M AndersonDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
Y UddinDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.ORCID 0000-0002-7383-7798
J WuDivision of Neurology, Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
S QiuDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.ORCID 0000-0002-0730-1602
University of Arizona · USSt. Joseph's Hospital and Medical Center · US

Funding

Met Signaling in Neural Development and Circuitry FormationR00MH087628 · NIMH · UNIVERSITY OF ARIZONA · PI QIU, SHENFENG · 2012 to 2014
$718k
Met Signaling in Neural Development and Circuitry FormationK99MH087628 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI QIU, SHENFENG · 2010 to 2011
$166k
NIMH NIH HHS K99 MH087628NIMH NIH HHS R00 MH087628
6 · The paper itself

Abstract

The human MET gene imparts a replicated risk for autism spectrum disorder (ASD), and is implicated in the structural and functional integrity of brain. MET encodes a receptor tyrosine kinase, MET, which has a pleiotropic role in embryogenesis and modifies a large number of neurodevelopmental events. Very little is known, however, on how MET signaling engages distinct cellular events to collectively affect brain development in ASD-relevant disease domains. Here, we show that MET protein expression is dynamically regulated and compartmentalized in developing neurons. MET is heavily expressed in neuronal growth cones at early developmental stages and its activation engages small GTPase Cdc42 to promote neuronal growth, dendritic arborization and spine formation. Genetic ablation of MET signaling in mouse dorsal pallium leads to altered neuronal morphology indicative of early functional maturation. In contrast, prolonged activation of MET represses the formation and functional maturation of glutamatergic synapses. Moreover, manipulating MET signaling levels in vivo in the developing prefrontal projection neurons disrupts the local circuit connectivity made onto these neurons. Therefore, normal time-delimited MET signaling is critical in regulating the timing of neuronal growth, glutamatergic synapse maturation and cortical circuit function. Dysregulated MET signaling may lead to pathological changes in forebrain maturation and connectivity, and thus contribute to the emergence of neurological symptoms associated with ASD.

Indexed as

AnimalsAutism Spectrum DisorderAutistic DisorderBrainCerebral CortexHumansMiceMice, Inbred C57BLNeurogenesisNeuronsProto-Oncogene Proteins c-metSignal TransductionSynapsesMET protein, humanProto-Oncogene Proteins c-met

Identifiers

PMID26728565
PMCPMC4914424
OpenAlexW2223839472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.